NEW YORK STOCK EXCHANGE, INC. · IQV
0.00% · $0.0000 · Vol Not reported
Market closed · last close shown
IQVIA Holdings Inc

IQVIA Holdings Inc

Life Sciences Tools & Services
$270.09
Card
Relationship Map

Follow $IQV

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $IQV by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measuredMethodology
IQV
IQVIA Holdings Inc
Tue Sep 22 · last completed session · Markets closed · resumes Wed 9:30 ET
Highest qualified

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

77/ 100
Veridion Score
Highest qualified · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: HIGH · 6 of 6 factors measured · Tue Sep 22 · last completed session · Markets closed · resumes Wed 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is IQV moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading IQV catalysts
About IQVIA Holdings Inc
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Listed since
2013
Employees
94K
Country
US

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$270.09
Last session
Day high
$270.09
Last session
Day low
$270.09
Last session
Previous close
$270.09
52W high
$271.62
-0.56% from high
52W low
$156.66
99% of range
Market cap
$44.4B
P/E
40.86×
EPS
$6.61
Beta
-0.01
Shares out
164.6M
Avg volume
1.5M
VWAP
$270.09
Last session
Price history computed in-house
1W
+0.47%
1M
+3.78%
3M
+44.87%
1Y
+44.86%
YTD
+19.82%
SMA 50 $243.83 · above
SMA 200 $204.06 · above
52W position 99%

IQV overview

Loading financial statements
Loading IQV Form 4 filings
Public disclosures

Congress activity in IQV

Hern Family Revocable Trust JTIQVIA Holdings, Inc. Common Stock · Transaction Mar 17, 2026 · Filed Date unavailable · $15,001 to $50,000

Official filing ↗
Federal contracts

IQV contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for IQV in this window.
Lobbying spend

IQV lobbying filings, year to date.

Registered lobbying filings matched to IQVIA Holdings Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for IQV in this window.
Loading news for IQV
Analyst ratings
Sovereign unlock shows live analyst consensus for IQV.
Options
Sovereign unlock shows live options positioning for IQV.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.